Abstract
Patients with relapsed/refractory Hodgkin lymphoma (RR-HL) who progress or relapse following autologous stem cell transplantation (ASCT) have historically had a poor prognosis. Several novel agents, particularly brentuximab vedotin, have shown efficacy in this setting. However, there remains a paucity of data characterizing outcomes outside of clinical trials and how these novel agents have impacted prognosis in general population of patients with RR-HL. Here, we conducted a retrospective analysis to evaluate outcomes in 87 patients with RR-HL with relapse post-ASCT. Treatment with novel agents (including brentuximab vedotin) was associated with significant improvement in median overall survival (OS) compared to patients who did not receive novel agents (85.6 vs 17.1 months; P < .001). Additional factors associated with improved OS in univariate analysis include treatment with radiation therapy post-ASCT (34.1 vs 17.0 months; P = .015), chemosensitivity (i.e., relapsed compared to primary refractory disease; 51.8 vs 25.6 months; p = 0.013), initial response to ASCT (i.e., CR/PR compared to SD/PD; 46.1 vs 20.4 months; P = .011), and transplantation in 2010 and later compared to prior to 2010 (not reached vs 24.5 months; P = .025...Continue Reading
References
Mar 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M G PfreundschuhR Kuse
Aug 1, 1996·Controlled Clinical Trials·M Schemper, T L Smith
Jun 28, 2002·Lancet·Norbert SchmitzUNKNOWN Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Nov 7, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Navneet S MajhailLinda J Burns
Jan 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Harmonization Project on Lymphoma
May 15, 2009·British Journal of Haematology·Alison J MoskowitzCraig H Moskowitz
Mar 17, 2010·American Journal of Hematology·Patrick B JohnstonThomas E Witzig
Mar 18, 2011·British Journal of Haematology·Stephen D SmithAlison J Moskowitz
Oct 4, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Panayotis KaloyannidisAchilles Anagnostopoulos
Sep 23, 2011·Blood·Todd A FehnigerNancy L Bartlett
Mar 29, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anas YounesRobert Chen
May 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anas YounesAndreas Engert
Apr 27, 2013·Leukemia & Lymphoma·Sally AraiSandra J Horning
May 29, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C MartínezUNKNOWN Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (EBMT) and the Gruppo Italiano Trapianto d
Oct 22, 2013·Leukemia & Lymphoma·Bastian von TresckowAndreas Engert
Dec 9, 2014·The New England Journal of Medicine·Stephen M AnsellPhilippe Armand
Dec 24, 2014·Blood·Ajay K GopalAnas Younes
Mar 17, 2015·Current Medical Research and Opinion·Vijayveer BonthapallyDirk Huebner
Mar 23, 2015·Lancet·Craig H MoskowitzUNKNOWN AETHERA Study Group
Jun 30, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philippe ArmandCraig H Moskowitz
Jul 20, 2016·Blood·Robert ChenAnas Younes
Jul 28, 2016·The Lancet Oncology·Anas YounesAndreas Engert
Aug 4, 2016·The Oncologist·Letizia GandolfiPier Luigi Zinzani
Dec 17, 2016·Cancer·Sarah A MilgromSunita D Nasta
Citations
Dec 20, 2016·Journal of Internal Medicine·I Glimelius, A Diepstra
Feb 28, 2018·Annals of Hematology·Mahmoud A ElshenawySaad Akhtar
Sep 25, 2018·The Cancer Journal·Kristie A Blum
May 18, 2019·American Society of Clinical Oncology Educational Book·Alison J MoskowitzAnne W Beaven
Dec 21, 2018·The Oncologist·Steven M BairJakub Svoboda
Jul 29, 2020·Leukemia & Lymphoma·Ahmed SawasOwen A O'Connor
Feb 29, 2020·Therapeutic Advances in Hematology·Theodoros P VassilakopoulosMaria K Angelopoulou
Jun 9, 2020·Annals of Hematology·Huseyin BekozBurhan Ferhanoglu
Aug 1, 2019·Cancers·Theodoros P VassilakopoulosKostas Konstantopoulos
Jul 31, 2020·Blood·Nancy L BartlettStephen M Ansell
Jul 1, 2020·Hematology/oncology and Stem Cell Therapy·Madiha Iqbal, Mohamed A Kharfan-Dabaja
Jul 14, 2021·Leukemia & Lymphoma·Leopoldine LapierreLucie Oberic
Sep 14, 2021·Journal of Chemotherapy·Bahar Uncu UluFevzi Altuntaş
Nov 17, 2021·Leukemia & Lymphoma·Harsh ShahAbhinav Deol